MedEdicus is a valued OOSS Resource Partner. RESOURCE PARTNERS provide products and services of interest to OOSS members. These partners support OOSS through their financial and in-kind contributions. Learn more about the OOSS Partner Program.

MedEdicus Logo

MedEdicus develops and implements continuing medical education programs specializing in ophthalmology. These programs include topics that would be of interest to OOSS members. MedEdicus CME programs are a great way to keep up to date and earn CME.


Proper management of intraoperative miosis and optimal assessment and treatment of inflammation and discomfort/pain associated with intraocular lens placement are important factors for maximizing cataract surgery outcomes. In this CME activity, experts will discuss practical and current evidence-based approaches to challenging cataract cases to optimize patient care.

This activity includes an opening page of instructions and credits, a short pre-test followed by a 40-minute video tutorial, and a post-test. To begin the pre-test and activity, click on the “next” button in the lower left corner of the first page.

Click here for a link to our complimentary CME activity:
Improving Outcomes of Complicated Cataract: Case Discussions on Intraoperative Miosis Control.


Glaucoma surgical procedures are shifting from traditional filtration procedures to minimally invasive glaucoma surgery (MIGS) procedures that take advantage of both traditional and nontraditional drainage pathways to offer significant intraocular pressure reductions and favorable safety profiles. This monograph reviews the MIGS procedures, including their different approaches to aqueous humor drainage, and provides guidance for selecting the appropriate device for each patient with glaucoma.

Click here for a link to our complimentary CME activity: Minimally Invasive Glaucoma Surgery: Clinical Experience From Europe, Canada, and the United States


New surgical procedures to achieve intraocular pressure levels in the low teens require antimetabolite augmentation. This monograph provides readers with an evidence-based review of antimetabolites and leading glaucoma specialists’ practical approaches to their use in glaucoma surgery.

Click here for a link to our complimentary CME activity: Mitomycin, MIGS, and Microstents:The Role of Antimetabolites in Glaucoma Surgery


Glaucoma continues to be the leading cause of irreversible blindness worldwide. This monograph provides ophthalmologists with an update on the mechanisms of action of current and emerging glaucoma therapies, including a review of the role of nitric oxide in intraocular pressure regulation, and assesses traditional and emerging risk factors for disease progression.

Click here for a link to our complimentary CME activity: The Pressure Is Still On! Current and Emerging Therapies for Managing Glaucoma


Understanding the pathophysiology of dry eye disease has provided a foundation for developments in diagnostic modalities and therapies. This monograph provides ophthalmologists with an update on the role of inflammation in the pathophysiology of dry eye disease and new diagnosis and treatment options.

Click here for a link to our complimentary CME activity: Current Opinions and Modern Approaches in the Diagnosis and Treatment Of Dry Eye Disease


New tools are enabling better dry eye disease recognition and classification, and new options are available for dry eye disease management. This monograph provides an update on dry eye disease diagnosis and management through a series of short articles and case-based discussions.

Click here for a link to our complimentary CME activity: Dry Eye Management for the 21st Century: Challenging Case Discussions